TYR and vitiligo: Treatment with monobenzone, a compound which results in melanocyte killing through haptenization of tyrosinase and induction of melanocyte autophagy [60], also leads to rejection of B16 melanoma tumors and the development of vitiligo when combined with TLR agonists [61].